Israël - anglais - Ministry of Health

dexcel pharma technologies ltd - losartan potassium - tablets - losartan potassium 50 mg - losartan - losartan - hypertension: losardex 50 is indicated for the treatment of hypertensionheart failure: losardex 50 is indicated for the treatment of heart failure, usually in addition to diuretics and/or digitalis, if use of an ace inhibitor is not appropriate.switching patients with heart failure who are stable on an ace inhibitor to losardex 50 is not recommended.renal protection in type-2 diabetic patients with proteinuria: losardex 50 is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine, end stage renal disease (need for dialysis or renal transplantation) or death; and to reduce proteinuria.reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. losardex 50 is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death, stroke, and myocardial infarction in hypertensive patients with left ventricular hypertrophy.the benefit of losardex 50 on the primary deposite endpoint was largely driven by reduction in the risk of stroke.

Israël - anglais - Ministry of Health

dexcel pharma technologies ltd - losartan potassium - tablets - losartan potassium 50 mg - losartan - losartan - hypertension: losardex 50 is indicated for the treatment of hypertensionheart failure: losardex 50 is indicated for the treatment of heart failure, usually in addition to diuretics and/or digitalis, if use of an ace inhibitor is not appropriate.switching patients with heart failure who are stable on an ace inhibitor to losardex 50 is not recommended.renal protection in type-2 diabetic patients with proteinuria: losardex 50 is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine, end stage renal disease (need for dialysis or renal transplantation) or death; and to reduce proteinuria.reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. losardex 50 is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death, stroke, and myocardial infarction in hypertensive patients with left ventricular hypertrophy.the benefit of losardex 50 on the primary deposite endpoint was largely driven by reduction in the risk of stroke.

Israël - anglais - Ministry of Health

dexcel pharma technologies ltd - losartan potassium - caplets - losartan potassium 100 mg - losartan - losartan - hypertension: losardex 100 is indicated for the treatment of hypertensionheart failure: losardex 100 is indicated for the treatment of heart failure, usually in addition to diuretics and/or digitalis, if use of an ace inhibitor is not appropriate.switching patients with heart failure who are stable on an ace inhibitor to losardex 100 is not recommended.renal protection in type-2 diabetic patients with proteinuria: losardex 100 is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine, end stage renal disease (need for dialysis or renal transplantation) or death; and to reduce proteinuria.reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. losardex 100 is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death, stroke, and myocardial infarction in hypertensive patients with left ventricular hypertrophy.the benefit of losardex 100 on the primary deposite endpoint was largely driven by reduction in the risk of stroke.

Israël - anglais - Ministry of Health

dexcel pharma technologies ltd - losartan potassium - caplets - losartan potassium 100 mg - losartan - losartan - hypertension: losardex 100 is indicated for the treatment of hypertensionheart failure: losardex 100 is indicated for the treatment of heart failure, usually in addition to diuretics and/or digitalis, if use of an ace inhibitor is not appropriate.switching patients with heart failure who are stable on an ace inhibitor to losardex 100 is not recommended.renal protection in type-2 diabetic patients with proteinuria: losardex 100 is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine, end stage renal disease (need for dialysis or renal transplantation) or death; and to reduce proteinuria.reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. losardex 100 is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death, stroke, and myocardial infarction in hypertensive patients with left ventricular hypertrophy.the benefit of losardex 100 on the primary deposite endpoint was largely driven by reduction in the risk of stroke.

Israël - anglais - Ministry of Health

lapidot medical import and marketing ltd - calcium chloride dihydrate; l-malic acid; magnesium chloride hexahydrate; potassium chloride; sodium acetate trihydrate; sodium chloride - solution for infusion - l-malic acid 0.67 g / 1000 ml; sodium acetate trihydrate 3.27 g / 1000 ml; calcium chloride dihydrate 0.37 g / 1000 ml; magnesium chloride hexahydrate 0.20 g / 1000 ml; potassium chloride 0.30 g / 1000 ml; sodium chloride 6.80 g / 1000 ml - electrolytes - replacement of extracellular fluid losses in the case of isotonic dehydration, where acidosis is present or imminent.

Canada - anglais - Health Canada

dr reckeweg canada - squill; adonis vernalis; convallaria majalis; helleborus niger; digitalis; hawthorn - liquid - 3x; 3x; 3x; 4x; 3x; 2x - squill 3x; adonis vernalis 3x; convallaria majalis 3x; helleborus niger 4x; digitalis 3x; hawthorn 2x - homeopathic products

Canada - anglais - Health Canada

dr reckeweg canada - strophanthus; hawthorn; cactus grandiflorus; kalmia latifolia; arsenic trioxide; phosphorus; digitalis - liquid - 2x; 800mg; 2x; 3x; 6x; 5x; 2x - strophanthus 2x; hawthorn 800mg; cactus grandiflorus 2x; kalmia latifolia 3x; arsenic trioxide 6x; phosphorus 5x; digitalis 2x - homeopathic products

États-Unis - anglais - NLM (National Library of Medicine)

nutritional specialties, inc. - garlic (unii: v1v998dc17) (garlic - unii:v1v998dc17), beef kidney (unii: 5hoc10fsic) (beef kidney - unii:5hoc10fsic), leonurus cardiaca whole (unii: 8nc0c2yxk0) (leonurus cardiaca - unii:8nc0c2yxk0), viscum album fruiting top (unii: bk9092j5mp) (viscum album fruiting top - unii:bk9092j5mp), gold (unii: 79y1949pyo) (gold - unii:79y1949pyo), digitalis (unii: f1t8qt9u8b) (digitalis - unii:f1t8qt9u8b), nitroglycerin (unii: g59m7s0ws3) (nitroglycerin - unii:g59m7s0ws3), lycopodium clavatum spore (unii: c8 - aids in temporary relief of headaches, frequent nosebleeds, excess water retention, nausea and dizziness.† †claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. aids in temporary relief of headaches, frequent nosebleeds, excess water retention, nausea and dizziness.† †claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

États-Unis - anglais - NLM (National Library of Medicine)

newton laboratories, inc. - micrurus corallinus venom (unii: v0s6h36980) (micrurus corallinus venom - unii:v0s6h36980), apis mellifera (unii: 7s82p3r43z) (apis mellifera - unii:7s82p3r43z), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), lytta vesicatoria (unii: 3q034ro3bt) (lytta vesicatoria - unii:3q034ro3bt), cinchona officinalis bark (unii: s003a158sb) (cinchona officinalis bark - unii:s003a158sb), colchicum autumnale bulb (unii: 993qhl78e6) (colchicum autumnale bulb - unii:993qhl78e6), convallaria majalis (unii: qhh4hvf5qe) (convallaria majalis - unii:qhh4hvf5qe), crotalus horridus horridus venom (unii: yha2xlj956) (crotalus horridus horridus venom - unii:yha2xlj956), digitalis (unii: f1t8qt9u8b) (digitalis - unii:f1t8qt9u8b), lachesis muta venom (unii: vsw71ss07i) (lachesis muta venom - unii:vsw71ss07i), mercury (unii: fxs1by2pgl) (mercury - unii:fxs1by2pgl), naja naja venom (unii: zz4ag7l7vm) (naja naja venom - unii:zz4ag7l7vm), sodium carbonate (unii: 45p3261c7t) (carbonate ion - unii:7ujq5ope7d), sodium sulfate (unii: 0ypr65r21j) (sodium sulfate anhydrous - unii:36kcs0r750), toxicodendron pubescens leaf (unii: 6io182rp7a) (toxicodendron pubescens leaf - unii:6io182rp7a), sambucus nigra flowering top (unii: ct03bsa18u) (sambucus nigra flowering top - unii:ct03bsa18u), strophanthus hispidus seed (unii: mo892vi77k) (strophanthus hispidus seed - unii:mo892vi77k), thuja occidentalis leafy twig (unii: 1nt28v9397) (thuja occidentalis leafy twig - unii:1nt28v9397), vipera berus venom (unii: 0oro6nca4m) (vipera berus venom - unii:0oro6nca4m), echinacea, unspecified (unii: 4n9p6cc1dx) (echinacea, unspecified - unii:4n9p6cc1dx), arctium lappa root (unii: 597e9bi3z3) (arctium lappa root - unii:597e9bi3z3), solidago virgaurea flowering top (unii: 5405k23s50) (solidago virgaurea flowering top - unii:5405k23s50), taraxacum officinale (unii: 39981fm375) (taraxacum officinale - unii:39981fm375), urtica urens (unii: ihn2nq5of9) (urtica urens - unii:ihn2nq5of9), juniper berry (unii: o84b5194rl) (juniper berry - unii:o84b5194rl) - formulated for associated symptoms such as skin discoloration, discomfort and swelling. formulated for associated symptoms such as skin discoloration, discomfort and swelling.

Irlande - anglais - HPRA (Health Products Regulatory Authority)

pharma-global limited - digitalin -